Glossary
Biomarker Identification Systems
Multi-Omics Data Integration
Terms related to the computational fusion of genomics, proteomics, and metabolomics data. Target: Bioinformatics leads and CTOs in precision medicine.
Multi-Omics Factor Analysis (MOFA)
An unsupervised statistical framework for integrating multiple omics data types by decomposing their variation into a sparse set of latent factors that capture the principal sources of biological and technical variability.
Canonical Correlation Analysis (CCA)
A statistical method for exploring relationships between two sets of high-dimensional variables by finding linear combinations that maximize their cross-correlation, widely used to identify coordinated patterns across different omics layers.
Sparse Canonical Correlation Analysis (Sparse CCA)
An extension of canonical correlation analysis that incorporates L1 or elastic net regularization to produce sparse linear combinations, selecting only the most relevant features from each omics dataset for improved interpretability.
Similarity Network Fusion (SNF)
A computational method that integrates multiple omics data types by constructing patient similarity networks for each data type and iteratively fusing them into a single comprehensive network capturing shared and complementary information.
DIABLO
A supervised multi-omics integration framework extending sparse generalized canonical correlation analysis to discriminate between phenotypic outcome classes while simultaneously selecting correlated molecular features across data blocks.
Multi-Omics Autoencoder
A neural network architecture that learns a compressed, non-linear latent representation of integrated multi-omics data by encoding high-dimensional inputs into a bottleneck layer and reconstructing the original modalities.
Variational Autoencoder (VAE)
A generative deep learning model that learns a probabilistic latent space representation of input data, enabling the integration of heterogeneous omics modalities and the generation of realistic synthetic molecular profiles.
Cross-Modal Attention
A deep learning mechanism that allows a model to dynamically weigh the relevance of features from one omics modality when processing another, capturing complex inter-modal molecular relationships for integrated prediction.
Graph Convolutional Network (GCN)
A type of neural network that operates directly on graph-structured data, used in multi-omics to model molecular interactions by propagating feature information across biological networks like protein-protein interaction graphs.
Knowledge Graph Embedding
A technique for representing entities and relations from a biomedical knowledge graph as low-dimensional vectors, enabling the integration of structured biological knowledge with experimental omics data for predictive modeling.
Non-Negative Matrix Factorization (NMF)
A dimensionality reduction technique that decomposes a non-negative data matrix into additive parts-based representations, used in multi-omics to identify coherent molecular signatures and mutational processes across data types.
Joint Dimensionality Reduction
A class of algorithms that simultaneously project multiple high-dimensional omics datasets into a shared low-dimensional subspace, preserving the joint structure and enabling integrated visualization and clustering of samples.
Pathway-Level Integration
A multi-omics integration strategy that maps individual molecular features to predefined biological pathways or gene sets before performing statistical analysis, enhancing biological interpretability and reducing dimensionality.
Proteogenomics
The integrated analysis of genomic, transcriptomic, and proteomic data from the same sample to identify novel protein-coding variants, improve genome annotation, and directly link genomic aberrations to protein expression changes.
Expression Quantitative Trait Loci (eQTL)
Genomic loci that explain a fraction of the variation in gene expression levels, serving as a foundational link between genetic variation and transcriptomic phenotype in integrative omics studies.
Mendelian Randomization (MR)
An epidemiological method that uses genetic variants as instrumental variables to test for causal effects of a modifiable molecular exposure on a disease outcome, reducing confounding in multi-omics association studies.
Multi-Kernel Learning (MKL)
A machine learning approach that combines multiple kernel functions, each representing a different omics data type or similarity measure, to learn an optimal composite kernel for improved classification or regression performance.
Deep Canonical Correlation Analysis (DCCA)
A non-linear extension of canonical correlation analysis using deep neural networks to learn maximally correlated complex transformations of two datasets, enabling the discovery of intricate cross-omics associations.
Multi-Omics Transformer
A deep learning architecture leveraging self-attention mechanisms to model long-range dependencies and complex interactions between tokens representing different molecular features from multiple omics layers simultaneously.
Cross-Omics Imputation
The computational task of predicting missing values in one omics modality using information from other available omics data types, leveraging cross-modal correlations to complete incomplete molecular profiles.
Multi-Omics Network Inference
The process of reconstructing molecular interaction networks by integrating multiple omics data sources, such as using genetic perturbations and expression data to infer directed regulatory relationships.
Elastic Net Regularization
A linear regression regularization method combining L1 and L2 penalties, frequently used in multi-omics biomarker discovery to perform automatic feature selection while handling groups of correlated molecular predictors.
Feature Fusion Layer
A neural network layer that concatenates or combines learned representations from separate modality-specific encoders into a single joint representation for downstream multi-omics prediction tasks.
Multi-Omics Embedding
A low-dimensional vector representation of a biological sample that encodes information from multiple integrated omics data types, serving as a unified molecular fingerprint for machine learning models.
Confounder Adjustment
A statistical process for removing the influence of extraneous variables that affect both the molecular exposure and the outcome, essential for preventing spurious associations in multi-omics data integration.
Harmonization Protocol
A standardized computational pipeline for preprocessing, normalizing, and formatting heterogeneous multi-omics datasets from different sources to ensure technical compatibility before downstream integrated analysis.
Multi-Omics Feature Store
A centralized data management layer that serves pre-computed, versioned, and harmonized multi-omics features for machine learning, ensuring consistency between training and inference in production biomarker systems.
Multi-Omics Metadata Standard
A community-driven specification for describing experimental protocols, sample annotations, and data processing steps for multi-omics studies, ensuring reproducibility and enabling large-scale data integration.
Tensor Decomposition
A multi-linear algebraic method for analyzing multi-dimensional data arrays, used to integrate multi-omics data by modeling interactions across features, samples, and omics modalities simultaneously.
Bayesian Consensus Clustering
A probabilistic integrative clustering approach that combines multiple clustering results from individual omics data types within a Bayesian framework to find a robust consensus partition of patient subgroups.
Protein Structure Prediction
Terms related to deep learning models like AlphaFold for determining 3D protein conformations. Target: Drug discovery heads and computational biology directors.
AlphaFold
A deep learning system developed by DeepMind that predicts a protein's 3D structure from its amino acid sequence with atomic accuracy.
Multiple Sequence Alignment (MSA)
A computational alignment of three or more biological sequences, typically proteins or nucleic acids, used to infer structural, functional, and evolutionary relationships.
Residue Coevolution
The statistical analysis of correlated mutations in a multiple sequence alignment to identify amino acid pairs that are likely in close spatial proximity within a protein's 3D structure.
Template-Based Modeling
A protein structure prediction method that uses the known experimental structure of a homologous protein as a template to construct a model of the target sequence.
Ab Initio Prediction
A computational method for predicting protein structure solely from physicochemical principles and the amino acid sequence, without relying on global structural templates.
SE(3) Equivariance
A mathematical property of a neural network ensuring that its predictions transform consistently with the rotation and translation of the input 3D coordinates.
Invariant Point Attention (IPA)
A core mechanism in AlphaFold2 that operates on 3D point clouds, updating representations in a way that is invariant to global rotation and translation.
Predicted Local Distance Difference Test (pLDDT)
A per-residue confidence metric output by AlphaFold, estimating the local accuracy of the predicted structure on a scale from 0 to 100.
Predicted Aligned Error (PAE)
A metric that estimates the expected positional error between any two residues in a predicted structure, useful for assessing domain packing and global confidence.
Evoformer
The core neural network block in AlphaFold2 that processes the multiple sequence alignment and pairwise representations to exchange information between them.
Structure Module
The final component of the AlphaFold2 architecture that takes abstract representations and iteratively generates a 3D protein structure as a set of residue frames.
Ramachandran Plot
A 2D plot of the phi and psi backbone dihedral angles of amino acid residues in a protein structure, used to validate the stereochemical quality of a model.
ProteinMPNN
A deep learning-based tool for inverse protein folding that generates amino acid sequences predicted to fold into a given 3D backbone structure.
De Novo Protein Design
The computational creation of entirely new protein sequences and structures that do not exist in nature, designed to perform a specific function.
CASP (Critical Assessment of Structure Prediction)
A biennial community-wide experiment that provides an objective, blind assessment of the state-of-the-art in protein structure prediction methods.
Global Distance Test (GDT_TS)
A primary scoring metric in CASP that measures the similarity between a predicted protein structure and the experimental structure, focusing on global topology.
Root Mean Square Deviation (RMSD)
A standard measure of the average distance between the atoms of superimposed protein structures, used to quantify the difference between a model and the native structure.
Protein Data Bank (PDB)
The single worldwide archive of experimentally determined 3D structures of proteins, nucleic acids, and complex assemblies, serving as the primary training data for prediction models.
Diffusion Models for Proteins
A class of generative models that learn to create novel protein structures by iteratively denoising random 3D coordinates, analogous to image generation techniques.
Inverse Folding
The computational task of designing an amino acid sequence that will fold into a specified target protein backbone structure.
Protein Language Model (pLM)
A large-scale neural network, such as ESM-2, trained on vast databases of protein sequences using self-supervised learning to capture evolutionary, structural, and functional information.
Molecular Dynamics Refinement
The application of physics-based simulations, often using force fields like AMBER, to optimize a predicted protein structure by resolving atomic clashes and bond geometry violations.
Side-Chain Packing
The computational process of predicting the optimal 3D conformations of amino acid side chains onto a fixed protein backbone, often using discrete rotamer libraries.
Quaternary Structure Prediction
The computational prediction of the 3D arrangement of multiple folded protein subunits in a multi-protein complex.
Intrinsically Disordered Proteins (IDP)
Proteins or protein regions that lack a stable 3D structure under physiological conditions, existing as a dynamic ensemble of conformations.
Deep Mutational Scanning (DMS)
A high-throughput experimental technique that measures the functional effect of thousands of genetic variants, providing massive datasets for training variant effect predictors.
Variant Effect Prediction
The computational task of predicting the impact of a single amino acid substitution on a protein's function, stability, or pathogenicity.
Conformational B-Cell Epitope
A specific 3D structural motif on an antigen's surface that is recognized and bound by antibodies, a key target for computational vaccine design.
Allostery
The regulation of a protein's function by the binding of an effector molecule at a site topographically distinct from the protein's active site.
Cryo-Electron Microscopy (Cryo-EM)
An experimental structural biology technique that images flash-frozen protein samples in their native state, providing critical training and validation data for prediction algorithms.
Differential Gene Expression Analysis
Terms related to statistical methods for identifying genes with altered activity between conditions. Target: Genomics researchers and biomarker discovery scientists.
Differential Expression Analysis
The statistical process of identifying genes whose expression levels show a significant quantitative change between two or more experimental conditions or biological groups.
Log2 Fold Change
A logarithmic transformation of the ratio of gene expression between two conditions, centered at zero, where positive values indicate up-regulation and negative values indicate down-regulation.
False Discovery Rate (FDR)
The expected proportion of false positives among all rejected null hypotheses, a critical error-control metric in high-dimensional genomic testing to manage the accumulation of Type I errors.
Benjamini-Hochberg Procedure
A widely used statistical method for controlling the False Discovery Rate by ranking raw p-values and comparing them to an adjusted significance threshold to determine statistical significance.
DESeq2
A widely adopted R/Bioconductor software package that uses a negative binomial distribution and empirical Bayes shrinkage to estimate dispersion and fold changes for differential gene expression analysis from raw count data.
edgeR
An R/Bioconductor software package designed for differential expression analysis of digital gene expression data, utilizing empirical Bayes estimation and exact tests based on the negative binomial distribution.
limma-voom
A differential expression workflow that applies the limma linear modeling framework to RNA-seq data by using the 'voom' transformation to convert discrete count data into continuous precision-weighted log-counts per million values.
Normalization (RNA-seq)
The computational process of adjusting raw read counts to remove systematic technical biases caused by varying sequencing depth, library composition, and gene length, enabling accurate between-sample comparisons.
Transcripts Per Million (TPM)
A gene expression normalization unit that first normalizes for gene length and then for sequencing depth, resulting in a metric where the sum of all TPMs in a sample equals one million, facilitating direct transcript proportion comparisons.
Negative Binomial Distribution
A discrete probability distribution commonly used to model RNA-seq count data because it accounts for overdispersion, where the variance of the counts exceeds the mean due to biological and technical variability.
Dispersion Estimation
The process of quantifying the gene-specific biological variability or 'spread' of count data around the mean, a crucial step in tools like DESeq2 and edgeR to accurately model variance and avoid false positives.
Empirical Bayes Shrinkage
A statistical technique used in genomic analysis to borrow information across all genes, stabilizing estimates of dispersion and fold change for genes with low counts or high variability by shrinking them toward a common prior distribution.
Wald Test
A parametric statistical hypothesis test used in differential expression analysis to determine if a model coefficient, such as the log2 fold change, is significantly different from zero by dividing the estimate by its standard error.
Volcano Plot
A scatter plot that visualizes the relationship between the magnitude of change (log2 fold change on the x-axis) and the statistical significance (-log10 p-value on the y-axis) for all genes, highlighting biologically significant outliers.
MA Plot
A diagnostic plot that displays the log-ratio of expression (M-value) against the mean average expression (A-value) for all genes, primarily used to visualize intensity-dependent biases and assess the effectiveness of normalization.
Batch Effect
A systematic non-biological source of variation in high-throughput experiments introduced by processing samples in different groups, on different days, or by different technicians, which can confound true biological signals.
ComBat-seq
A batch effect correction algorithm specifically designed for RNA-seq count data that uses a negative binomial regression model to adjust for known technical covariates while preserving the integer nature of the counts.
Pseudobulk Analysis
A computational strategy for single-cell differential expression where reads from individual cells are aggregated by sample and cell type to create a synthetic 'bulk' profile, enabling the use of established tools like DESeq2 and edgeR.
Wilcoxon Rank Sum Test
A non-parametric statistical test commonly used in single-cell differential expression analysis to compare the distribution of gene expression between two groups without assuming a specific data distribution.
Differential Transcript Usage (DTU)
The analysis of changes in the relative abundance of alternative mRNA isoforms from the same gene between conditions, capturing regulatory mechanisms that differential gene expression analysis alone would miss.
DEXSeq
An R/Bioconductor package designed for differential exon usage analysis, which tests for condition-dependent changes in the relative usage of individual exonic regions using a generalized linear model framework.
Expression Quantitative Trait Locus (eQTL)
A genomic locus, typically a single nucleotide polymorphism, that is statistically associated with the variation in the expression level of a gene, linking genetic variation to transcriptional regulation.
Weighted Gene Co-expression Network Analysis (WGCNA)
A systems biology method for identifying clusters or 'modules' of highly correlated genes across samples, summarizing module behavior with an eigengene, and relating these modules to external clinical traits.
Gene Set Enrichment Analysis (GSEA)
A computational method that determines whether a predefined set of genes shows statistically significant, concordant differences between two biological states, without relying on an arbitrary differential expression cutoff.
Design Matrix
A mathematical matrix that encodes the experimental design, specifying which samples belong to which conditions and any covariates, serving as the input to the linear model in differential expression analysis.
Multiple Testing Correction
A class of statistical adjustments applied to p-values when performing thousands of simultaneous hypothesis tests on a microarray or RNA-seq dataset to control the probability of making one or more Type I errors.
Trimmed Mean of M-values (TMM)
A robust normalization method implemented in edgeR that estimates scale factors between samples by computing a weighted trimmed mean of the log expression ratios, after excluding highly variable and lowly expressed genes.
Counts Per Million (CPM)
A simple normalization unit representing the raw read count for a gene scaled by the total number of mapped reads in the sample and multiplied by one million, primarily used for filtering lowly expressed genes.
Variance Stabilizing Transformation (VST)
A data transformation applied to RNA-seq count data, such as the one implemented in DESeq2, that renders the variance approximately independent of the mean, making the data suitable for visualization techniques like PCA and heatmaps.
Principal Component Analysis (PCA)
An unsupervised dimensionality reduction technique used in genomics to visualize the primary sources of variation in a dataset, often revealing sample clustering driven by biological conditions or technical batch effects.
Pathway Enrichment Analysis
Terms related to identifying biological pathways significantly associated with differentially expressed genes. Target: Translational researchers and systems biology engineers.
Gene Set Enrichment Analysis (GSEA)
A computational method that determines whether a priori defined sets of genes show statistically significant, concordant differences between two biological states.
Over-Representation Analysis (ORA)
A statistical method that identifies gene sets or pathways that are over-represented in a list of differentially expressed genes using a hypergeometric distribution or Fisher's exact test.
Functional Class Scoring (FCS)
A category of enrichment methods that ranks all genes by a differential expression statistic and evaluates the aggregate trend of a gene set within that ranking.
Pathway Topology Analysis
An enrichment approach that incorporates the structural dependencies, interaction types, and signaling directionality of a pathway's molecular network into the statistical assessment.
Gene Ontology (GO)
A structured, species-independent bioinformatics framework that provides a controlled vocabulary of terms to describe gene product attributes across biological process, molecular function, and cellular component.
Kyoto Encyclopedia of Genes and Genomes (KEGG)
An integrated database resource consisting of manually curated pathway maps representing molecular interaction and reaction networks for metabolism, genetic information processing, and cellular processes.
Reactome
An open-source, manually curated, and peer-reviewed pathway database that provides detailed molecular details of signal transduction, transport, DNA replication, and other cellular processes.
Molecular Signatures Database (MSigDB)
A comprehensive collection of annotated gene sets for use with Gene Set Enrichment Analysis, including positional, curated, motif, computational, GO, oncogenic, and immunologic signature collections.
Enrichment Score (ES)
The maximum deviation from zero encountered by a running-sum statistic during a Gene Set Enrichment Analysis, reflecting the degree to which a gene set is overrepresented at the extremes of a ranked list.
Normalized Enrichment Score (NES)
An enrichment score corrected for differences in gene set size and correlation with the expression dataset, enabling comparative analysis of enrichment results across multiple gene sets.
False Discovery Rate (FDR)
The expected proportion of false positives among all rejected null hypotheses, commonly estimated via the Benjamini-Hochberg procedure to correct for multiple hypothesis testing in enrichment analysis.
Multiple Hypothesis Testing Correction
A set of statistical adjustments applied to p-values when performing simultaneous inference on thousands of gene sets to control the probability of false positive findings.
Leading-Edge Subset
The core group of genes within an enriched gene set that contributes most significantly to the enrichment signal, appearing at the extreme ends of the ranked expression list.
Gene Set Variation Analysis (GSVA)
A non-parametric, unsupervised method that estimates the variation of pathway activity over a sample population in an experiment without requiring a defined phenotype contrast.
Single-Sample GSEA (ssGSEA)
An extension of Gene Set Enrichment Analysis that calculates separate enrichment scores for each pairing of a sample and gene set, enabling pathway activity inference for individual samples.
Competitive Gene Set Test
A statistical hypothesis test that assesses whether genes within a specific set are more differentially expressed than genes outside the set, comparing the set against a background complement.
Self-Contained Gene Set Test
A statistical hypothesis test that evaluates whether a specific gene set is differentially expressed without reference to other genes, testing only the null hypothesis of no change within the set itself.
Hypergeometric Distribution
A discrete probability distribution used in Over-Representation Analysis to model the probability of observing a specific number of differentially expressed genes within a pathway by random chance.
Running Sum Statistic
A sequential calculation used in GSEA that walks down a ranked gene list, increasing when a gene is in the target set and decreasing otherwise, to detect non-random clustering of the set.
Enrichment Map
A network-based visualization method that organizes enriched gene sets into a similarity network where nodes represent gene sets and edges represent mutual overlap between their leading-edge genes.
DAVID (Database for Annotation, Visualization, and Integrated Discovery)
A web-based bioinformatics tool suite providing functional interpretation of large gene lists through integrated annotation databases and enrichment analysis algorithms.
Enrichr
A collaborative web-based gene set enrichment analysis tool that integrates a massive compendium of gene set libraries and employs a novel background correction strategy for ranking enriched terms.
Gene Set Collection
A curated or computationally derived library of gene sets, typically stored in GMT file format, representing shared biological features, chromosomal locations, or regulatory motifs for enrichment testing.
GMT File Format
A tab-delimited text file format for storing gene set databases where each row contains a gene set name, a description, and the list of gene identifiers belonging to the set.
Pathway Crosstalk
The phenomenon of overlapping gene membership and signaling interactions between distinct biological pathways that can confound the statistical independence assumptions of enrichment analysis.
Semantic Similarity of GO Terms
A computational measure that quantifies the functional relatedness between two Gene Ontology terms based on the information content of their shared ancestors in the ontology graph.
WikiPathways
An open, collaborative platform for the curation and dissemination of biological pathway models, enabling community-driven editing and integration with analysis tools.
Hallmark Gene Sets
A refined collection of 50 specific biological states and processes within MSigDB, generated by a computational methodology that reduces redundancy and noise from overlapping founder gene sets.
Phenotype Permutation
A resampling strategy for estimating the null distribution in GSEA by randomly shuffling sample phenotype labels while preserving the correlation structure of the gene expression data.
Pathway Visualization
The graphical representation of enrichment results on biological network diagrams, often using tools like Pathview to overlay experimental data onto canonical pathway structures.
Survival Analysis Models
Terms related to time-to-event modeling for patient prognosis and treatment response prediction. Target: Clinical trial statisticians and oncology informaticians.
Cox Proportional Hazards Model
A semiparametric regression model that quantifies the effect of covariates on the hazard rate without specifying the baseline hazard function, foundational for survival analysis.
Kaplan-Meier Estimator
A non-parametric statistic used to estimate the survival function from lifetime data, handling right-censored observations to visualize time-to-event probabilities.
Hazard Ratio
The ratio of hazard rates between two groups, representing the instantaneous relative risk of an event occurring at a specific time, commonly derived from the Cox model.
Censoring Mechanisms
The statistical processes describing why event times are incomplete, including right-censoring, left-truncation, and interval-censoring, which dictate the appropriate analytical method.
Competing Risks Model
A survival analysis framework that accounts for events that preclude the occurrence of the primary event of interest, using metrics like the Cumulative Incidence Function.
Fine-Gray Subdistribution Hazard Model
A regression method for competing risks data that directly models the effect of covariates on the cumulative incidence function without requiring proportional hazards on the cause-specific hazards.
Time-Varying Covariates
Predictor variables whose values change over the observation period, requiring extended Cox models or landmark analysis to avoid immortal time bias in longitudinal studies.
Frailty Models
Survival models incorporating random effects to account for unobserved heterogeneity or clustering within groups, such as shared frailty for multicenter clinical trial data.
Concordance Index (C-Index)
A rank-based performance metric evaluating the discriminative ability of a survival model by measuring the proportion of patient pairs whose predicted risk aligns with actual event order.
Brier Score for Survival
A strictly proper scoring rule that measures the mean squared difference between predicted survival probabilities and observed event status at a specific time, assessing calibration and discrimination.
Schoenfeld Residuals
Diagnostic residuals used to test the proportional hazards assumption by checking if the effect of a covariate is constant over time, often visualized with the Grambsch-Therneau test.
Martingale Residuals
Residuals used to assess the functional form of covariates in a Cox model by plotting them against continuous predictors to detect non-linearity or outliers.
Restricted Mean Survival Time (RMST)
The area under the survival curve up to a specified time point, providing a clinically interpretable summary of treatment benefit without relying on the proportional hazards assumption.
Accelerated Failure Time (AFT) Model
A parametric regression model where covariates directly accelerate or decelerate the time to an event, assuming a specific distribution like Weibull or log-normal for the survival time.
Random Survival Forests
An ensemble tree-based method extending random forests to handle censored data, capable of modeling complex non-linear effects and high-order interactions for survival prediction.
DeepSurv
A deep feed-forward neural network adaptation of the Cox proportional hazards model, designed to learn complex non-linear relationships between patient covariates and treatment-specific survival risk.
Joint Models for Longitudinal and Survival Data
Statistical frameworks that simultaneously model a longitudinal biomarker trajectory and a time-to-event outcome to correct for measurement error and assess dynamic risk prediction.
Inverse Probability Censoring Weighting (IPCW)
A technique to correct for bias from dependent or informative censoring by weighting uncensored observations by the inverse of their estimated probability of remaining uncensored.
Dynamic Prediction
The process of updating a patient's survival prognosis as new longitudinal data, such as repeated lab measurements, becomes available, often using landmarking or joint modeling.
Cure Models
Survival models that assume a fraction of the population will never experience the event of interest, separating the cured fraction from the survival distribution of uncured subjects.
Multi-State Models
An extension of survival analysis that models transitions between multiple discrete states, such as healthy, disease progression, and death, rather than a single terminal event.
Recurrent Events Analysis
Statistical methods for analyzing repeated occurrences of the same event type within a subject, using models like Andersen-Gill or Prentice-Williams-Peterson to account for within-subject correlation.
Lasso Cox Regression
A penalized Cox model applying an L1 penalty to shrink coefficients toward zero, performing automatic feature selection for high-dimensional survival data like genomic biomarkers.
Time-Dependent ROC Curve
An extension of the receiver operating characteristic curve that evaluates the ability of a marker or model to discriminate between subjects who will and will not experience an event by a specific time.
Calibration Plots for Survival Models
Graphical diagnostics that compare predicted survival probabilities against observed event rates across risk groups to assess the absolute accuracy of a prognostic model.
Patient Stratification Algorithms
Terms related to unsupervised learning for identifying clinically meaningful patient subgroups. Target: Precision medicine directors and clinical data scientists.
Unsupervised Clustering
A machine learning technique for grouping patients based on inherent data similarities without predefined labels, revealing natural disease subtypes.
Dimensionality Reduction
The process of reducing the number of random variables under consideration by obtaining a set of principal variables, essential for visualizing high-dimensional patient data.
Principal Component Analysis (PCA)
A linear dimensionality reduction technique that transforms high-dimensional data into a set of orthogonal principal components ordered by the variance they explain.
t-Distributed Stochastic Neighbor Embedding (t-SNE)
A non-linear dimensionality reduction algorithm particularly well-suited for visualizing high-dimensional single-cell and patient data in a low-dimensional space.
Uniform Manifold Approximation and Projection (UMAP)
A manifold learning technique for dimension reduction that better preserves the global data structure than t-SNE, widely used for visualizing patient cohorts.
K-Means Clustering
A centroid-based algorithm that partitions patients into a predefined number of clusters by minimizing the within-cluster variance of features.
Hierarchical Clustering
An algorithm that builds a hierarchy of patient clusters, often visualized as a dendrogram, without requiring a pre-specified number of groups.
Gaussian Mixture Models (GMM)
A probabilistic model that assumes all data points are generated from a mixture of a finite number of Gaussian distributions, providing soft cluster assignments.
DBSCAN
A density-based clustering algorithm that groups together patients in high-density regions and identifies outliers as noise, without requiring a predefined cluster count.
Consensus Clustering
A resampling-based methodology that aggregates results from multiple clustering runs to identify robust and stable patient subgroups.
Patient Similarity Networks
Graph-based representations where nodes are patients and edges represent clinical or molecular similarity, enabling community detection for stratification.
Louvain Algorithm
A greedy optimization method for community detection in large networks that maximizes modularity to identify densely connected patient groups.
Deep Embedded Clustering (DEC)
A method that simultaneously learns feature representations with an autoencoder and assigns clusters in the latent space to improve patient stratification.
Multi-Omics Factor Analysis (MOFA)
A statistical framework for the unsupervised integration of multiple omics data types to discover the principal sources of biological variation driving patient subgroups.
Similarity Network Fusion (SNF)
A computational method for integrating diverse patient data types by constructing and fusing patient similarity networks into a single comprehensive view.
Trajectory Inference
A computational method that orders patients or cells along a continuous path based on molecular profiles, modeling dynamic disease progression rather than discrete clusters.
Hidden Markov Models (HMM)
A statistical model for sequential data used in longitudinal clustering to model transitions between unobserved health states over time.
Fuzzy C-Means
A soft clustering algorithm that allows a patient to belong to multiple clusters with varying degrees of membership, reflecting clinical ambiguity.
Silhouette Score
An internal cluster validation metric that measures how similar a patient is to its own cluster compared to other clusters, ranging from -1 to 1.
Cluster Stability Analysis
A validation framework that assesses the robustness of patient clusters by measuring their reproducibility under data perturbation or resampling.
Bayesian Nonparametrics
A class of models, such as the Dirichlet Process Mixture, that allow the number of patient clusters to grow with the data rather than being fixed a priori.
Topological Data Analysis (TDA)
A method for studying the shape of complex patient data using persistent homology to detect high-dimensional voids and connectivity patterns.
Endotype Discovery
The process of identifying distinct disease subtypes defined by a specific functional or pathobiological mechanism, moving beyond clinical phenotype to molecular cause.
Subspace Clustering
An extension of traditional clustering that identifies patient groups that are similar only in a specific subset of features, handling high-dimensional data effectively.
Self-Organizing Maps (SOM)
A type of artificial neural network that uses unsupervised learning to produce a low-dimensional, discretized representation of the input space, preserving topological properties.
Affinity Propagation
A clustering algorithm that identifies exemplars among data points and forms clusters by passing messages between pairs of samples until convergence.
HDBSCAN
A hierarchical density-based clustering extension of DBSCAN that extracts a flat clustering based on cluster stability, robustly handling varying density clusters.
Patient Stratification
The clinical process of partitioning a heterogeneous patient population into distinct subgroups based on molecular or clinical characteristics to guide treatment decisions.
Molecular Taxonomy
A classification system for diseases based on their molecular and genetic signatures rather than solely on histology or anatomical site of origin.
Risk Stratification
The process of categorizing patients into groups based on their predicted probability of experiencing a specific adverse clinical outcome or disease progression.
Digital Pathology Biomarkers
Terms related to deep learning extraction of quantitative features from whole-slide images. Target: Pathology informatics leads and diagnostic AI developers.
Whole-Slide Image (WSI)
A high-resolution digital scan of an entire glass pathology slide, typically stored as a multi-resolution gigapixel pyramid for computational analysis.
Tissue Microarray (TMA)
A high-throughput technique that assembles hundreds of small tissue cores into a single paraffin block, enabling simultaneous biomarker analysis across many patient samples on one slide.
Stain Normalization
A computational pre-processing technique that standardizes the color appearance of histology images to reduce variability caused by different staining protocols and scanners.
Immunohistochemistry (IHC)
A laboratory staining method that uses antibodies to detect specific protein antigens in tissue sections, visualized through enzymatic color reactions for biomarker quantification.
Multiplex Immunofluorescence (mIF)
An advanced imaging technique that simultaneously labels multiple protein markers on a single tissue section using distinct fluorophores, enabling spatial profiling of the tumor microenvironment.
Semantic Segmentation
A deep learning task that classifies every pixel in an image into predefined tissue categories, such as tumor, stroma, or necrosis, without distinguishing individual object instances.
Instance Segmentation
A computer vision task that detects and delineates each individual object boundary within an image, such as separating touching nuclei, assigning a unique mask to every cell.
Multiple Instance Learning (MIL)
A weakly-supervised learning paradigm where a model is trained using slide-level labels by aggregating predictions from unlabeled patches extracted from a gigapixel whole-slide image.
Tumor-Infiltrating Lymphocytes (TILs)
Immune cells that have migrated from the bloodstream into a tumor, whose density and spatial distribution are quantified as prognostic and predictive biomarkers for immunotherapy response.
Ki-67 Index
A proliferation biomarker calculated as the percentage of tumor cells staining positive for the Ki-67 protein, used to assess tumor aggressiveness and guide treatment decisions.
HER2 Scoring
A standardized immunohistochemical assessment of human epidermal growth factor receptor 2 overexpression on breast cancer cell membranes, determining eligibility for targeted anti-HER2 therapy.
Gleason Grading
A histopathological scoring system that classifies prostate cancer aggressiveness based on the architectural patterns of tumor gland formation observed in tissue biopsies.
Computational Pathology
An interdisciplinary field applying machine learning and image analysis algorithms to digitized tissue slides for automated diagnosis, biomarker discovery, and outcome prediction.
Vision Transformer (ViT)
A neural architecture that applies the self-attention mechanism to sequences of image patches, capturing long-range spatial dependencies for state-of-the-art pathology image classification.
Foundation Model
A large-scale pre-trained model, such as UNI or Virchow, trained on massive histology datasets using self-supervised learning to generate general-purpose visual features transferable to diverse downstream tasks.
Attention Heatmap
A visualization technique that highlights the image regions most influential to a deep learning model's decision, providing spatial interpretability for slide-level classification.
Pathomics
The high-throughput extraction and mining of hundreds of quantitative morphological, textural, and spatial features from digital pathology images to characterize tumor heterogeneity.
Spatial Omics Integration
The computational fusion of spatially-resolved molecular data, such as transcriptomics or proteomics, with histology images to map gene expression patterns onto tissue architecture.
Prognostic Biomarker
A biological characteristic objectively measured in a tumor sample that provides information about patient outcome, such as overall survival, independent of treatment received.
Predictive Biomarker
A biological characteristic that identifies patients likely to benefit from a specific targeted therapy, such as PD-L1 expression predicting response to checkpoint inhibitors.
Concordance Index (C-Index)
A performance metric evaluating the discriminative ability of a prognostic model by measuring the proportion of patient pairs for which predicted and observed survival times are correctly ordered.
Image Quality Control
An automated pre-processing pipeline that detects artifacts like tissue folds, pen marks, air bubbles, and out-of-focus regions to exclude non-diagnostic image content before analysis.
Inter-Observer Variability
The statistical disagreement between pathologists when annotating or grading the same tissue, often quantified using Cohen's Kappa to establish the ground truth difficulty of a diagnostic task.
Dice Coefficient
A spatial overlap metric measuring the similarity between a predicted segmentation mask and the pathologist's ground truth annotation, commonly used to evaluate nuclear or gland detection models.
Graph Neural Network (GNN)
A deep learning architecture that operates on graph-structured data, modeling cells as nodes and their spatial relationships as edges to capture the tissue microenvironment topology.
U-Net
A convolutional encoder-decoder architecture with skip connections, widely adopted as the baseline model for biomedical image segmentation tasks such as nuclear or gland delineation.
Hover-Net
A specialized deep learning architecture that simultaneously performs nuclear segmentation and classification by predicting horizontal and vertical gradient maps to separate touching cells.
Tumor Mutational Burden (TMB)
A quantitative genomic biomarker measuring the total number of somatic mutations per coding area of a tumor genome, used to predict response to immune checkpoint inhibitor therapy.
Microsatellite Instability (MSI)
A genomic phenotype of hypermutation caused by defective mismatch repair, identified computationally from sequencing data as a pan-cancer biomarker for immunotherapy eligibility.
Federated Learning
A privacy-preserving distributed training paradigm where multiple institutions collaboratively train a pathology model by sharing only encrypted gradient updates without transferring patient image data.
Liquid Biopsy Analytics
Terms related to machine learning analysis of circulating tumor DNA and rare cell populations. Target: Oncology diagnostics engineers and cancer early-detection researchers.
Cell-Free DNA (cfDNA)
Short fragments of DNA released into the bloodstream through cell death and secretion, serving as the primary analyte in liquid biopsy for non-invasive cancer detection and monitoring.
Circulating Tumor DNA (ctDNA)
The fraction of cell-free DNA originating specifically from tumor cells, carrying cancer-specific somatic mutations used as a biomarker for minimal residual disease and treatment response.
Variant Allele Frequency (VAF)
The percentage of sequencing reads at a specific genomic locus that contain a variant allele, used to estimate the proportion of mutated DNA molecules in a heterogeneous sample.
Unique Molecular Identifier (UMI)
A random nucleotide barcode ligated to individual DNA molecules before amplification, enabling computational deduplication and absolute quantification of original template molecules.
Duplex Sequencing
An error-correction method that independently sequences both strands of a DNA duplex using complementary UMIs to distinguish true mutations from polymerase errors and base damage.
Limit of Detection (LoD)
The lowest concentration of analyte that can be reliably distinguished from background noise, defining the analytical sensitivity floor of a liquid biopsy assay.
Clonal Hematopoiesis Filter
A computational or matched-control strategy to exclude somatic variants originating from age-related clonal expansions in blood cells rather than from a solid tumor.
Fragmentomics
The study of cell-free DNA fragmentation patterns, including fragment length, end motifs, and nucleosome positioning, to infer the tissue of origin and epigenetic state.
Copy Number Alteration (CNA)
A somatic structural change resulting in the gain or loss of chromosomal segments, detectable in cfDNA through read-depth analysis and used as a pan-cancer biomarker.
Tumor Mutational Burden (TMB)
A quantitative measure of the total number of somatic coding mutations per megabase of tumor genome, used as a predictive biomarker for immunotherapy response.
Microsatellite Instability (MSI)
A hypermutable phenotype caused by deficient DNA mismatch repair, characterized by length alterations in repetitive DNA sequences and detectable via targeted cfDNA analysis.
Molecular Barcode
A synthetic nucleotide sequence incorporated into library adapters to uniquely tag individual starting molecules, enabling error suppression and accurate variant counting.
Base Quality Recalibration (BQR)
A machine learning process that adjusts per-base quality scores emitted by the sequencer using empirically observed error covariates to improve variant calling accuracy.
Germline Filtering
The computational subtraction of inherited polymorphisms from a somatic variant callset by comparison against a matched normal sample or population database.
Panel of Normals (PoN)
A curated collection of sequencing data from healthy individuals used to model and suppress systematic technical artifacts and recurrent background noise in a somatic variant caller.
Somatic Variant Caller
A specialized algorithm designed to distinguish low-frequency true somatic mutations from germline variants, sequencing errors, and mapping artifacts in tumor-normal paired or tumor-only sequencing data.
Mutational Signature
A characteristic pattern of nucleotide substitution contexts imprinted on a tumor genome by specific mutagenic processes, computationally deconvolved to identify etiological drivers.
Methylation Pattern
The distribution of 5-methylcytosine modifications across CpG dinucleotides, serving as a tissue-specific epigenetic fingerprint for determining the cell of origin of cfDNA.
Digital Droplet PCR (ddPCR)
An ultrasensitive nucleic acid quantification method that partitions a sample into thousands of nanoliter-sized droplets, enabling absolute counting of rare mutant molecules without a standard curve.
GC Bias Correction
A computational normalization step that models and removes the non-linear relationship between fragment guanine-cytosine content and sequencing coverage to improve copy number accuracy.
Index Hopping
A sequencing artifact where sample barcodes are misassigned due to index-switching during cluster amplification, causing sample cross-contamination that must be computationally mitigated.
Library Complexity
The number of unique, non-duplicate DNA molecules in a sequencing library, reflecting the diversity of the original input material and the quantitative power of the assay.
Targeted Error Correction
A bioinformatic strategy that leverages molecular barcodes and redundant sequencing to build consensus sequences, suppressing random polymerase and sequencer errors below the variant detection threshold.
Subclonal Architecture
The inferred population structure of genetically distinct tumor cell clusters within a patient, reconstructed from the distribution of variant allele frequencies across multiple mutations.
Nucleosome Footprint
The characteristic fragmentation pattern of cfDNA reflecting the protection of DNA wrapped around histone octamers, providing information about gene regulatory elements and cell-type origin.
Single-Cell Sequencing Analysis
Terms related to computational methods for resolving cellular heterogeneity from individual cell transcriptomes. Target: Immunology researchers and single-cell core facility directors.
scRNA-seq
Single-cell RNA sequencing, a high-throughput technology that profiles the transcriptome of individual cells to resolve heterogeneity masked in bulk sequencing.
Unique Molecular Identifier (UMI)
A random barcode sequence incorporated during library preparation to tag individual transcripts, enabling absolute molecular counting and PCR duplicate removal.
Doublet Detection
Computational identification and removal of erroneous cell barcodes that represent two or more cells captured in a single droplet or microwell.
Ambient RNA
Cell-free mRNA molecules present in the cell suspension that contaminate droplets, producing background counts that require computational correction.
Count Matrix
A sparse numerical matrix where rows represent genes and columns represent cell barcodes, storing the number of transcripts detected per gene in each cell.
Dimensionality Reduction
Mathematical transformation of high-dimensional single-cell data into a lower-dimensional space for visualization and noise reduction, commonly using PCA, t-SNE, or UMAP.
Graph-Based Clustering
An unsupervised method that partitions cells into groups by constructing a nearest-neighbor graph and applying community detection algorithms like Louvain or Leiden.
Marker Gene
A gene whose expression is highly specific to a particular cell type or state, used as a diagnostic feature for annotation and classification.
Pseudotime
A quantitative measure of a cell's progression along a continuous biological process, such as differentiation, inferred from transcriptomic similarity rather than real clock time.
RNA Velocity
A computational method that predicts the future transcriptional state of individual cells by distinguishing between unspliced and spliced mRNA reads.
Trajectory Inference
The computational reconstruction of dynamic biological paths, such as developmental lineages, by ordering cells based on transcriptomic similarity in pseudotime.
Batch Effect
Non-biological systematic variation introduced by technical factors like different experimental runs, reagents, or sequencing lanes that confounds biological signal.
Data Integration
Computational alignment of multiple single-cell datasets to remove batch effects while preserving true biological variation across conditions or experiments.
Normalization
The process of scaling raw count data to adjust for differences in sequencing depth and capture efficiency between cells, enabling valid cross-cell comparisons.
Highly Variable Genes (HVG)
Genes exhibiting greater expression variance across cells than expected by technical noise, selected as informative features for downstream dimensionality reduction.
Cell Type Annotation
The assignment of biological identity labels to cell clusters using curated marker gene databases, reference mapping, or automated classification algorithms.
Label Transfer
A computational technique that projects cell-type annotations from a well-characterized reference dataset onto an unlabeled query dataset using shared latent space representations.
Differential Expression Testing
Statistical comparison of gene expression levels between cell groups or conditions to identify transcripts that are significantly up- or down-regulated.
Quality Control (QC)
The initial filtering step that removes low-quality cells based on metrics like total counts, number of genes detected, and mitochondrial read fraction.
Cell Hashing
A multiplexing technique that labels cells from different samples with distinct oligonucleotide-tagged antibodies, enabling sample pooling and computational demultiplexing.
CITE-seq
Cellular Indexing of Transcriptomes and Epitopes by Sequencing, a multimodal assay that simultaneously profiles RNA expression and surface protein abundance in single cells.
Multimodal Integration
The computational fusion of disparate single-cell data types, such as RNA and protein or chromatin accessibility, into a unified representation for joint analysis.
Seurat
A widely adopted R package for single-cell RNA-seq quality control, analysis, and exploration, providing a comprehensive framework for data integration and visualization.
Scanpy
A scalable Python-based toolkit for analyzing single-cell gene expression data built on the AnnData data structure, enabling preprocessing, clustering, and trajectory inference.
Gene Regulatory Network (GRN)
A computational model that maps the regulatory relationships between transcription factors and their target genes, inferred from co-expression or chromatin accessibility data.
scATAC-seq
Single-cell Assay for Transposase-Accessible Chromatin using sequencing, a method that profiles open chromatin regions to infer regulatory element activity in individual cells.
Ligand-Receptor Analysis
Computational inference of cell-cell communication by mapping the expression of ligand genes in one cell type to cognate receptor genes in another.
Imputation
The computational correction of dropout events in single-cell data by borrowing information from similar cells to recover gene expression values falsely observed as zero.
Spatial Transcriptomics
A family of technologies that maps gene expression measurements onto their physical locations within a tissue section, preserving spatial context.
Foundation Model
A large-scale pre-trained model, such as scGPT or Geneformer, trained on massive single-cell corpora using self-supervised learning to generate transferable cell and gene embeddings.
Spatial Transcriptomics
Terms related to algorithms that map gene expression patterns onto tissue architecture. Target: Neuroscience researchers and spatial biology platform developers.
Spatial Transcriptomics
A collection of molecular biology methods used to assign gene expression measurements to specific locations within a tissue section, preserving spatial context.
Spatial Barcoding
A technique that uses spatially indexed oligonucleotide arrays to capture mRNA from tissue sections, enabling the mapping of transcriptomic data back to its original location.
In Situ Hybridization (ISH)
A molecular technique that uses labeled complementary nucleic acid probes to localize specific DNA or RNA sequences directly within fixed tissue or cells.
In Situ Sequencing (ISS)
A method for directly reading out the sequence of RNA transcripts within preserved tissue by performing rolling circle amplification and sequencing-by-ligation on-site.
Spatial Deconvolution
A computational process that estimates the proportions of different cell types within a spatial transcriptomics spot by separating the mixed gene expression signal.
Spatially Variable Genes (SVG)
Genes whose expression levels exhibit a statistically significant dependence on spatial location within a tissue, indicating non-random distribution patterns.
Laser Capture Microdissection (LCM)
A technique that uses a focused laser beam to isolate specific cells or regions of interest from a heterogeneous tissue section for downstream genomic or proteomic analysis.
Tissue Segmentation
The computational process of partitioning a digital tissue image into distinct anatomical or functional regions based on pixel-level classification.
Cell Segmentation
The task of identifying and delineating the boundaries of individual cells within microscopy images, a critical preprocessing step for single-cell spatial analysis.
Spatial Autocorrelation
A statistical measure of the degree to which a variable's values at nearby locations in a tissue are more similar than expected by random chance.
Moran's I
A spatial autocorrelation statistic that measures the overall clustering of a gene expression pattern across a tissue, ranging from dispersed to highly clustered.
Ripley's K Function
A spatial point pattern analysis tool used to determine if cells or molecular events are clustered, dispersed, or randomly distributed across multiple distance scales.
Ligand-Receptor Co-localization
A computational analysis that identifies spatially proximal cell-type pairs where a ligand gene in one cell type and its cognate receptor gene in another are co-expressed.
Spatial Trajectory Inference
A computational method that orders cells based on their spatial coordinates and gene expression profiles to reconstruct dynamic biological processes like differentiation in situ.
Spatial Registration
The computational alignment of multiple tissue images or spatial datasets into a common coordinate system to enable integrative cross-modality analysis.
Spatial Graph Neural Network
A deep learning architecture that operates on graph representations of spatial data, where nodes represent cells or spots and edges represent spatial proximity, to learn context-aware representations.
Spatial Domain Detection
The unsupervised identification of tissue regions with coherent gene expression profiles and histology, often achieved through graph-based clustering or hidden Markov models.
Spatial Niche Analysis
The characterization of the cellular microenvironment by identifying recurrent cell-type compositions and their spatial interactions within a tissue.
Spatial Batch Correction
A computational method for removing technical variation between multiple spatial transcriptomic samples or experiments while preserving true biological spatial heterogeneity.
Spatial Imputation
A computational technique for predicting the expression of unmeasured genes or enhancing the resolution of sparse spatial transcriptomics data by leveraging gene-gene and spatial correlations.
Spatial Multi-Omics Integration
The computational fusion of spatial transcriptomics data with other spatially resolved modalities, such as proteomics or epigenomics, from the same or adjacent tissue sections.
Spatial Resolution
The minimum physical distance at which two distinct molecular signals can be differentiated in a spatial assay, ranging from subcellular to multi-cellular spot levels.
Spatial Differential Expression
A statistical framework for identifying genes whose expression changes significantly between user-defined spatial regions or tissue annotations.
Spatial Permutation Test
A non-parametric statistical test that randomly shuffles spatial labels to generate a null distribution for assessing the significance of observed spatial patterns.
Spatial Hidden Markov Model
A probabilistic model that infers unobserved spatial domains by assuming that the observed gene expression at each location depends on a hidden state with spatial dependencies.
Spatial Point Process
A statistical model for the random distribution of points in space, used to analyze the arrangement of individual cells or mRNA molecules in spatial transcriptomics data.
Spatial Transcriptomic Atlas
A comprehensive, reference-quality map of gene expression across an entire organ or organism, integrating multiple spatial datasets to define canonical tissue structures.
Spatial Data Integration
The process of combining multiple spatial transcriptomics datasets from different technologies, samples, or modalities into a unified, harmonized analytical framework.
Spatial Dropout
The stochastic failure to capture a transcript that is present in a tissue location, leading to an excess of zeros in spatial expression matrices and requiring specialized statistical models.
Spatial Neighborhood Graph
A data structure where each spatial location is a node, and edges connect neighboring locations based on a distance threshold or k-nearest neighbors, enabling spatial-aware computation.
Radiomics Feature Extraction
Terms related to high-throughput mining of quantitative imaging features from medical scans. Target: Radiology AI engineers and oncological imaging specialists.
Radiomics
The high-throughput extraction and analysis of quantitative features from medical images to create mineable data for decision support.
Texture Analysis
A set of mathematical methods for quantifying the spatial arrangement of pixel or voxel intensities to characterize tissue heterogeneity.
Gray-Level Co-occurrence Matrix (GLCM)
A second-order statistical method that quantifies texture by calculating how often pairs of pixels with specific values occur in a defined spatial relationship.
Gray-Level Run Length Matrix (GLRLM)
A texture matrix that counts the number of consecutive pixels with the same gray-level value in a specific direction to capture structural coarseness.
Gray-Level Size Zone Matrix (GLSZM)
A texture matrix that quantifies the size of connected regions of identical gray-level values, independent of their directional orientation.
Neighborhood Gray-Tone Difference Matrix (NGTDM)
A texture matrix that quantifies the difference between a pixel's gray value and the average gray value of its surrounding neighbors.
First-Order Statistics
Histogram-based metrics that describe the distribution of individual voxel intensities without considering spatial relationships, including mean, median, and skewness.
Shape Features
Quantitative descriptors of a region of interest's three-dimensional geometric properties, such as volume, sphericity, and surface-to-volume ratio.
Wavelet Transform
A mathematical decomposition technique that filters an image into different frequency sub-bands to extract multi-scale texture features not visible in the spatial domain.
Laplacian of Gaussian (LoG) Filter
An edge-detection filter that applies Gaussian smoothing before computing the Laplacian to highlight regions of rapid intensity change at various scales.
Image Biomarker Standardisation Initiative (IBSI)
An independent international collaboration that establishes consensus-based reference standards for radiomic feature definitions and image processing workflows.
Feature Harmonization
The computational process of removing unwanted technical variability from radiomic features caused by differences in scanner models or acquisition protocols.
ComBat Harmonization
A statistical batch-effect correction method originally developed for genomics and adapted to radiomics to standardize feature values across multiple imaging centers.
Voxel Resampling
The process of interpolating medical image data to create isotropic voxels, ensuring spatial measurements are consistent across all three dimensions.
Intensity Discretization
The process of converting continuous image intensity values into a finite number of discrete bins, a critical pre-processing step for texture matrix calculation.
Hounsfield Unit (HU) Rescaling
The normalization of computed tomography pixel values to a standardized scale based on the radiodensity of water, enabling cross-scanner tissue density comparisons.
PyRadiomics
An open-source Python package implementing a standardized pipeline for the extraction of a large panel of engineered features from medical image data.
Robust Feature Selection
A dimensionality reduction strategy that identifies and retains only radiomic features demonstrating high stability against test-retest and inter-observer variability.
Dimensionality Reduction
A mathematical process for reducing the number of random variables under consideration, often using techniques like PCA to avoid overfitting in high-dimensional radiomic datasets.
Principal Component Analysis (PCA)
An unsupervised linear transformation technique that converts correlated radiomic features into a set of linearly uncorrelated principal components.
Delta-Radiomics
The extraction and analysis of changes in radiomic features over time or across different phases of treatment to capture temporal tumor dynamics.
Deep Radiomics
The use of deep convolutional neural networks to automatically learn hierarchical feature representations directly from medical images, bypassing handcrafted feature engineering.
Region of Interest (ROI) Delineation
The process of defining the boundary of a specific anatomical structure or tumor on a medical image slice for targeted feature extraction.
Volume of Interest (VOI)
A three-dimensional contour encompassing a specific anatomical structure or lesion across multiple image slices for volumetric feature extraction.
Entropy
A first-order statistical measure of the randomness or disorder in the distribution of voxel intensity values within a region of interest.
Kurtosis
A first-order statistical measure of the 'peakedness' or tailedness of the intensity histogram, indicating the concentration of values around the mean.
Skewness
A first-order statistical measure of the asymmetry of the intensity histogram distribution around the mean value.
Homogeneity
A GLCM-based texture measure that quantifies the closeness of the distribution of elements in the matrix to the diagonal, indicating local uniformity.
Radiomic Signature
A composite biomarker consisting of a specific set of weighted radiomic features combined via a mathematical model to predict a clinical endpoint.
Test-Retest Reproducibility
The assessment of the stability of radiomic feature measurements when imaging is repeated on the same subject under identical conditions within a short interval.
Causal Inference in Biomedicine
Terms related to Mendelian randomization and causal discovery algorithms for identifying true disease drivers. Target: Genetic epidemiologists and target validation scientists.
Mendelian Randomization (MR)
An instrumental variable analysis method that uses genetic variants as proxies for modifiable exposures to estimate causal effects on health outcomes, minimizing confounding and reverse causation.
Instrumental Variable Analysis
A statistical technique for estimating causal relationships when controlled experiments are infeasible, using a third variable (the instrument) to account for unobserved confounding between the exposure and outcome.
Horizontal Pleiotropy
A violation of the Mendelian randomization exclusion restriction where a genetic variant influences the outcome through pathways independent of the exposure under investigation, introducing bias.
Causal Directed Acyclic Graph (DAG)
A graphical representation of causal assumptions where nodes represent variables and directed edges represent direct causal effects, containing no feedback loops to ensure acyclicity.
Do-Calculus
A formal mathematical framework developed by Judea Pearl for reasoning about interventions and deriving causal effects from observational data using the do-operator.
Counterfactual Reasoning
A causal inference framework that estimates what would have happened to an individual's outcome if they had received a different exposure than the one they actually experienced.
Average Treatment Effect (ATE)
The mean difference in outcomes between a population where everyone received a treatment and the same population where everyone received a control condition.
Inverse-Variance Weighting (IVW)
A fixed-effect meta-analysis method in Mendelian randomization that combines causal effect estimates from multiple genetic instruments, weighting each by the inverse of its variance.
MR-Egger Regression
A pleiotropy-robust Mendelian randomization method that allows for directional horizontal pleiotropy by fitting a weighted linear regression with an unconstrained intercept term.
MR-PRESSO
The Mendelian Randomization Pleiotropy RESidual Sum and Outlier test, a method for detecting and correcting for horizontal pleiotropy by identifying and removing outlier genetic variants.
Cis-Mendelian Randomization
A Mendelian randomization study design that uses genetic variants located within or near the gene encoding the exposure (e.g., a protein or gene expression) as instruments to minimize pleiotropy.
Two-Sample Mendelian Randomization
A Mendelian randomization design where the genetic variant-exposure associations and genetic variant-outcome associations are estimated from two independent, non-overlapping study populations.
Multivariable Mendelian Randomization (MVMR)
An extension of Mendelian randomization that estimates the direct causal effect of multiple correlated exposures on an outcome simultaneously, accounting for shared genetic architecture.
Causal Mediation Analysis
A statistical framework for decomposing a total causal effect into a direct effect and an indirect effect that operates through one or more intermediate variables (mediators).
GWAS Summary Statistics
Aggregated results from a genome-wide association study, typically including effect sizes, standard errors, and p-values for millions of genetic variants, used as input for downstream causal inference.
Linkage Disequilibrium Score Regression (LDSC)
A technique that uses summary statistics to estimate heritability and genetic correlations, and to distinguish between polygenic signals and confounding biases like population stratification.
Colocalization Analysis
A statistical method to assess whether two potentially related traits share the same causal genetic variant at a given genomic locus, supporting a shared causal mechanism.
Phenome-Wide Mendelian Randomization (Phe-MR)
A hypothesis-free approach that systematically tests the causal effect of a single exposure on hundreds or thousands of outcomes across the human phenome using Mendelian randomization.
Causal Discovery Algorithm
A class of algorithms that infers causal structures directly from observational data by testing conditional independencies, without requiring a pre-specified causal hypothesis.
PC Algorithm
A constraint-based causal discovery algorithm named after its creators, Peter and Clark, that learns a partial ancestral graph by systematically testing conditional independence relationships.
Structural Equation Modeling (SEM)
A multivariate statistical analysis technique that models complex relationships between observed and latent variables, combining factor analysis and path analysis to test hypothesized causal structures.
Granger Causality
A statistical concept of causality based on prediction, where a time series X is said to Granger-cause Y if past values of X improve the prediction of Y beyond using past values of Y alone.
Propensity Score Matching (PSM)
A causal inference method that attempts to mimic randomization by matching treated and untreated units with similar estimated probabilities of receiving the treatment based on observed covariates.
Difference-in-Differences (DiD)
A quasi-experimental design that estimates a treatment effect by comparing the change in outcome over time between a treated group and an untreated control group.
Target Trial Emulation
A framework for designing observational studies by explicitly specifying the protocol of a hypothetical randomized trial that would answer the causal question, then emulating it with observational data.
Marginal Structural Model (MSM)
A class of causal models that estimates the marginal effect of a time-varying treatment on an outcome, typically using inverse probability of treatment weighting to adjust for time-dependent confounding.
Collider Bias
A systematic distortion that arises when conditioning on a common effect (collider) of two variables, inducing a spurious association between them even if they are independent.
Weak Instrument Bias
A bias in instrumental variable analysis, including Mendelian randomization, that occurs when the genetic variants used as instruments are only weakly associated with the exposure, leading to inflated and unreliable causal estimates.
Expression Quantitative Trait Loci (eQTL)
Genomic loci that are statistically associated with the expression level of one or more genes, often used as instruments in Mendelian randomization studies of gene expression.
Drug Target Mendelian Randomization
An application of Mendelian randomization that uses genetic variants within or near a drug target gene to predict the efficacy and potential side effects of modifying that target pharmaceutically.
Batch Effect Normalization
Terms related to computational correction of non-biological experimental variation in high-throughput data. Target: Core facility bioinformaticians and multi-center study coordinators.
Batch Effect
A systematic non-biological source of variation introduced across different experimental batches, such as different processing dates, reagents, or technicians, which can confound downstream analysis.
ComBat
An empirical Bayes framework for adjusting batch effects in high-dimensional data, originally developed for microarray gene expression, which robustly estimates location and scale adjustments using a hierarchical model.
Harmony
An iterative clustering algorithm that projects cells into a shared embedding where it softly clusters cells by both cell type and dataset of origin to correct for batch effects in single-cell RNA sequencing data.
Mutual Nearest Neighbors (MNN)
A batch correction method that identifies pairs of cells from different batches that are mutual nearest neighbors in a high-dimensional expression space and uses these pairs to estimate a correction vector.
Seurat Integration
A computational workflow that identifies cross-dataset anchors using canonical correlation analysis and uses these anchors to integrate and harmonize disparate single-cell datasets into a shared reference.
Canonical Correlation Analysis (CCA)
A statistical technique used in data integration to find linear combinations of features from two datasets that are maximally correlated, enabling the alignment of cells from different batches into a common low-dimensional space.
Surrogate Variable Analysis (SVA)
A statistical method that estimates and removes the effects of unmodeled, latent sources of variation, such as batch effects, directly from high-dimensional data without requiring knowledge of the batch variable.
Remove Unwanted Variation (RUVSeq)
A normalization strategy that uses negative control genes or replicate samples to estimate and remove factors of unwanted technical variation, such as batch effects, from RNA sequencing data.
Trimmed Mean of M-values (TMM)
A normalization method for RNA-seq data that estimates scale factors between samples by computing a weighted trimmed mean of the log expression ratios, assuming most genes are not differentially expressed.
DESeq2 Normalization
A variance-stabilizing normalization procedure that uses a median-of-ratios method to estimate size factors, followed by a negative binomial model to account for the inherent dispersion in count-based sequencing data.
Variance Stabilizing Transformation (VST)
A data transformation applied to count-based sequencing data to render the variance independent of the mean, making the data more homoskedastic and suitable for linear modeling techniques like PCA.
k-nearest Neighbor Batch Effect Test (kBET)
A quantitative metric that evaluates the degree of batch mixing by comparing the local batch label distribution in a k-nearest neighbor graph to the global batch distribution, with a perfect mix yielding a chi-squared test acceptance rate near 1.0.
Local Inverse Simpson's Index (LISI)
A diversity score computed for each cell's local neighborhood that quantifies the effective number of different batches (iLISI) or cell types (cLISI) present, used to assess the harmony of integrated data.
Average Silhouette Width (ASW)
A metric used to evaluate batch correction by measuring the cohesion of cell-type clusters against the separation of batch labels, where a high cell-type ASW and low batch ASW indicates successful integration.
Scanorama
An algorithm for integrating heterogeneous single-cell datasets that identifies mutual nearest neighbors across all pairs of datasets and stitches them together into a unified panorama, effectively correcting for batch effects.
BBKNN (Batch-balanced KNN)
A graph-based data integration algorithm that constructs a k-nearest neighbor graph where each cell is connected to neighbors from each batch independently, effectively removing batch structure from the neighborhood graph.
LIGER (Linked Inference of Genomic Experimental Relationships)
An integrative non-negative matrix factorization method that identifies shared and dataset-specific factors from single-cell data, enabling the alignment of cells from different batches by their shared biological signals.
Confounding Factor
A variable that is correlated with both the independent variable of interest and the dependent outcome, such as a batch effect that is perfectly confounded with a biological condition, making it impossible to separate their effects.
Design Matrix
A mathematical matrix representing the experimental design in a linear model, where columns encode known covariates like biological conditions and batch identifiers, allowing for the explicit modeling and removal of batch effects.
Domain-Adversarial Neural Network (DANN)
A deep learning architecture that jointly learns a label predictor and a domain classifier connected by a gradient reversal layer, forcing the feature extractor to learn representations that are discriminative for the main task but invariant to the batch domain.
scVI (Single-cell Variational Inference)
A deep generative model based on a variational autoencoder that models single-cell RNA-seq data with a zero-inflated negative binomial distribution, explicitly accounting for batch effects as a latent variable for probabilistic normalization.
Optimal Transport
A mathematical framework for comparing probability distributions that is used in batch correction to find a minimal-cost mapping or coupling between cells from different batches, aligning their distributions in a principled manner.
Maximum Mean Discrepancy (MMD)
A kernel-based statistical test used as a loss function in deep learning to measure the distance between two probability distributions, enabling the alignment of latent feature distributions from different batches.
Overcorrection Assessment
The process of evaluating whether a batch correction method has removed true biological variation alongside technical noise, often measured by the preservation of known cell-type clusters or the variance explained by biological covariates.
Batch Confounding
A critical experimental design flaw where the batch variable is perfectly correlated with the biological condition of interest, making it statistically impossible to separate technical artifacts from the true biological signal.
Linear Mixed Model (LMM)
A statistical model containing both fixed effects, such as the biological condition, and random effects, such as the batch identifier, allowing for the estimation of biological differences while accounting for the correlation structure introduced by batches.
Quantile Normalization
A global adjustment method that forces the empirical distribution of values in each sample to be identical, typically by projecting them onto a reference distribution, making it a strong but potentially aggressive batch correction technique.
Residual Batch Effect
Systematic technical variation that remains in a dataset after an initial batch correction procedure has been applied, often requiring a secondary, post-hoc correction step or indicating an incomplete modeling of the experimental design.
Contrastive Learning
A self-supervised representation learning paradigm used for batch correction that pulls together augmented views of the same biological sample while pushing apart samples from different batches, learning batch-invariant features.
Entropy of Batch Mixing
An information-theoretic metric that quantifies the randomness of batch labels within a defined local neighborhood of cells, where high entropy indicates a well-mixed, successfully integrated dataset free of local batch clustering.
Feature Selection for High-Dimensional Data
Terms related to LASSO, elastic net, and other methods for identifying robust biomarkers in wide datasets. Target: Machine learning engineers in diagnostics and prognostic model developers.
LASSO (L1 Regularization)
A linear regression method that performs both variable selection and regularization by adding a penalty equal to the absolute value of the magnitude of coefficients, shrinking some to exactly zero.
Elastic Net
A regularized regression method that linearly combines the L1 and L2 penalties of the LASSO and ridge methods to handle highly correlated features and perform grouped selection.
Recursive Feature Elimination (RFE)
A wrapper method that recursively removes the least important features based on a model's coefficient weights or feature importance scores to find the optimal subset.
Boruta
An all-relevant feature selection algorithm that uses a random forest classifier to compare the importance of real features against randomly shuffled shadow features.
Minimum Redundancy Maximum Relevance (mRMR)
A filter method that selects features by maximizing their relevance to the target variable while minimizing the mutual information redundancy among the selected features.
Stability Selection
A robust feature selection method that combines subsampling with a high-dimensional selection algorithm like LASSO and selects features that are consistently chosen across many random data perturbations.
Principal Component Analysis (PCA)
An unsupervised linear dimensionality reduction technique that transforms data into a new coordinate system of orthogonal principal components, ordered by the amount of variance they explain.
Sparse PCA
A variant of principal component analysis that produces modified principal components with sparse loadings, making the results more interpretable by using only a subset of the original features.
Autoencoder Feature Extraction
An unsupervised neural network architecture that learns a compressed, lower-dimensional representation of input data by training the network to reconstruct the input from a bottleneck layer.
Group LASSO
An extension of the LASSO that performs variable selection on predefined groups of features, either selecting or discarding all members of a group together.
Sure Independence Screening (SIS)
A fast, scalable two-stage procedure for ultra-high-dimensional data that first screens features by their marginal correlation with the response before applying a refined selection method like LASSO.
Benjamini-Hochberg Procedure
A statistical method for controlling the false discovery rate when performing multiple hypothesis tests, often used to select statistically significant features from thousands of univariate tests.
SHAP Feature Selection
A model-agnostic selection technique that uses Shapley additive explanations to quantify the contribution of each feature to a model's prediction, selecting those with the highest global importance.
Permutation Feature Importance
A model inspection technique that measures the decrease in a model's performance score when a single feature's values are randomly shuffled, breaking its relationship with the target.
Knockoff Filter
A statistical framework for controlled variable selection that creates synthetic 'knockoff' variables mimicking the correlation structure of the original features to act as negative controls for false discovery rate estimation.
Concrete Autoencoder
A deep learning architecture for unsupervised feature selection that uses a concrete relaxation of the discrete distribution in its bottleneck layer to learn a subset of the most informative input features.
Variance Inflation Factor (VIF)
A diagnostic measure that quantifies the severity of multicollinearity in a regression analysis, used to iteratively remove features that are highly predictable from other features.
ReliefF Algorithm
A distance-based filter method that estimates feature quality by how well a feature's values distinguish between instances that are near to each other but belong to different classes.
Weighted Gene Co-Expression Network Analysis (WGCNA)
A systems biology method for finding clusters of highly correlated genes, summarizing them by a module eigengene, and relating these modules to external clinical traits for biomarker discovery.
Clumping and Thresholding
A standard technique in genome-wide association studies that selects independent significant genetic variants by first applying a p-value threshold and then pruning correlated variants within a linkage disequilibrium window.
LDpred
A Bayesian polygenic risk score method that infers the posterior mean effect size of all genetic markers by accounting for the local linkage disequilibrium pattern and a prior on the genetic architecture.
Mendelian Randomization Selection
A causal inference method that uses genetic variants as instrumental variables to select and validate modifiable risk factors that have a causal effect on a disease outcome.
Maximal Information Coefficient (MIC)
A measure of association that captures a wide range of functional and non-functional relationships between two variables, used as a filter method to select features with any strong dependency on the target.
Non-Negative Matrix Factorization (NMF)
A group of algorithms that factorize a high-dimensional matrix into two lower-dimensional, non-negative matrices, yielding a parts-based, sparse representation useful for extracting latent features.
Sparse Bayesian Learning
A regression framework that uses a hierarchical prior, such as the automatic relevance determination prior, to encourage sparsity, automatically pruning irrelevant features during the Bayesian inference process.
Markov Blanket Selection
A causal feature selection method that identifies the minimal set of variables that makes a target variable conditionally independent of all other variables, revealing direct causes, effects, and confounders.
Sparse Partial Least Squares (sPLS)
A dimensionality reduction method that integrates the feature selection of LASSO with the latent variable modeling of partial least squares to find sparse linear combinations of features that maximize covariance with a response.
Deep Feature Selection
A neural network architecture that adds a one-to-one sparse linear layer between the input and the first hidden layer, allowing the model to perform embedded feature selection during standard deep learning training.
Federated Feature Selection
A privacy-preserving computational paradigm that allows multiple data holders to collaboratively compute a common set of important features without sharing their raw, decentralized data.
Ensemble Feature Selection
A robust approach that applies multiple different feature selection algorithms to the same dataset and aggregates their results, often through rank aggregation, to produce a more stable and reliable final feature set.
Synthetic Patient Data Generation
Terms related to generative adversarial networks for creating privacy-preserving, realistic medical datasets. Target: Healthcare AI governance leads and clinical data access committees.
Generative Adversarial Network (GAN)
A deep learning architecture where two neural networks, a generator and a discriminator, compete in a zero-sum game to produce increasingly realistic synthetic data.
Wasserstein GAN (WGAN)
A GAN variant that uses the Wasserstein distance as a loss function to improve training stability and provide a meaningful convergence metric by minimizing the earth mover's distance between real and generated distributions.
Conditional GAN (cGAN)
A GAN architecture that conditions both the generator and discriminator on auxiliary information, such as class labels or data modalities, enabling controlled generation of specific data types.
Differential Privacy (DP)
A mathematical framework that provides provable privacy guarantees by injecting calibrated noise into data or algorithms, ensuring that the output does not reveal the presence or absence of any single individual in the dataset.
Membership Inference Attack
A privacy attack where an adversary determines whether a specific data record was used to train a machine learning model, exposing potential data leakage from synthetic or production models.
Synthetic Data Vault (SDV)
An open-source ecosystem of generative models for creating synthetic tabular, relational, and time-series data while preserving statistical properties and business logic from original datasets.
CTGAN
A conditional tabular GAN designed to model non-Gaussian, multimodal continuous columns and discrete columns with class imbalance, enabling high-fidelity synthetic generation of heterogeneous tabular data.
Synthetic Data Quality Score
A composite metric evaluating synthetic data across three dimensions: statistical fidelity to the original data, utility for downstream machine learning tasks, and privacy protection against re-identification.
Nearest Neighbor Adversarial Accuracy (NNAA)
A privacy metric that measures the difficulty of distinguishing real from synthetic records by comparing distances to nearest neighbors, quantifying identifiability risk in generated datasets.
Train-Synthetic-Test-Real (TSTR)
An evaluation paradigm where a model is trained entirely on synthetic data and tested on real data, measuring the utility of synthetic data by its ability to substitute for real data in downstream tasks.
Time-Series GAN (TimeGAN)
A generative model combining unsupervised GAN training with supervised autoregressive objectives to capture temporal dynamics and produce realistic sequential synthetic data.
Electronic Health Record Generation
The process of creating synthetic patient records that preserve clinical correlations and temporal disease trajectories while ensuring patient privacy and compliance with healthcare regulations.
K-Anonymity
A privacy model ensuring that each released record is indistinguishable from at least k-1 other records with respect to quasi-identifiers, preventing direct re-identification in synthetic datasets.
Frechet Inception Distance (FID)
A metric for evaluating synthetic data quality by comparing the distribution of features extracted from a pre-trained model, measuring both visual fidelity and diversity of generated samples.
Variational Autoencoder (VAE)
A generative model that learns a latent representation by maximizing the evidence lower bound, encoding data into a probabilistic distribution and decoding samples back to the original space.
Denoising Diffusion Probabilistic Model (DDPM)
A generative model that progressively adds noise to data in a forward process and learns to reverse this corruption, generating high-fidelity samples through iterative denoising steps.
Causal Generative Model
A generative model that incorporates causal structure and do-calculus to generate counterfactual data points, enabling the simulation of interventions and removal of confounding biases in synthetic datasets.
Clinical Plausibility
The degree to which synthetic medical data adheres to established physiological constraints, medical ontologies like SNOMED CT, and realistic disease progression pathways.
Synthetic Data Watermarking
A technique for embedding imperceptible, verifiable digital fingerprints into synthetic data to enable provenance tracking, leak detection, and authentication of generated datasets.
Model Card
A structured transparency document detailing a machine learning model's intended use, evaluation results, and limitations, adapted for synthetic data generators to disclose privacy and fairness assessments.
FairGAN
A GAN architecture designed to generate synthetic data that mitigates bias by enforcing statistical parity or equalized odds constraints, producing fair representations for downstream model training.
Adversarial Validation
A technique for detecting distribution shift between training and test sets by training a classifier to distinguish them; used to evaluate whether synthetic data faithfully represents the real data distribution.
Federated Distillation
A privacy-preserving technique where synthetic data is generated from the aggregated knowledge of teacher models trained in isolation across decentralized data silos, without sharing raw data.
Homomorphic Encryption
A cryptographic method enabling computation directly on encrypted data, allowing generative models to train on sensitive health records without decrypting them, preserving patient confidentiality.
Safe Harbor De-identification
A HIPAA-defined standard requiring the removal of 18 specific identifiers from health data; synthetic data must clear this threshold to be considered de-identified for clinical research use.
Partially Synthetic Data
A dataset where only sensitive or high-risk variables are synthesized while non-sensitive, structurally critical fields are retained from the original data, balancing utility and privacy.
Bayesian Network
A probabilistic graphical model representing conditional dependencies via a directed acyclic graph, used to generate synthetic data by sampling from learned joint probability distributions.
Normalizing Flow
A generative model that transforms a simple base distribution into a complex target distribution through a sequence of invertible, differentiable mappings, enabling exact likelihood computation.
Propensity Score Matching
A statistical method for evaluating synthetic data utility by comparing the similarity of propensity score distributions between real and generated datasets, measuring covariate balance.
Data Valuation
The process of quantifying the marginal contribution of individual data points to model performance, using methods like Data Shapley to identify high-value records for targeted synthetic augmentation.
Federated Learning for Healthcare
Terms related to decentralized model training across hospitals without sharing patient data. Target: Hospital system CIOs and multi-site clinical research network architects.
Federated Averaging (FedAvg)
The foundational federated learning algorithm that combines locally trained model weights from multiple clients by averaging them on a central server to create a global model without accessing raw data.
Differential Privacy (DP)
A mathematical framework that injects calibrated statistical noise into data or model updates to provide a provable guarantee that the presence or absence of any single individual's record cannot be inferred.
Secure Aggregation
A cryptographic protocol that allows a central server to compute the sum of model updates from multiple clients while ensuring the server cannot inspect any individual client's contribution in plaintext.
Homomorphic Encryption (HE)
A cryptographic scheme that enables computation directly on encrypted data, producing an encrypted result that, when decrypted, matches the output of operations performed on the original plaintext.
Non-IID Data
A data distribution characteristic in federated settings where local client datasets are statistically heterogeneous and do not represent the overall population distribution, posing a significant convergence challenge.
Cross-Silo Federated Learning
A federated learning topology designed for a small number of reliable institutional clients, such as hospitals, that hold large, curated datasets and participate in every training round.
Cross-Device Federated Learning
A federated learning topology designed for a massive scale of unreliable edge devices, such as smartphones, characterized by intermittent availability, limited compute, and high client dropout rates.
Model Inversion Attack
A privacy attack where an adversary analyzes a trained machine learning model's outputs or gradients to reconstruct representative samples of the private training data used to create it.
Federated Transfer Learning (FTL)
A technique that applies transfer learning within a federated framework to handle scenarios where participating clients have datasets with different feature spaces or different label spaces.
Vertical Federated Learning
A federated learning paradigm where collaborating parties hold data with different features about the same set of overlapping entities, requiring entity alignment and split neural network training.
Horizontal Federated Learning
A federated learning paradigm where collaborating parties hold data with the same feature space but different sample spaces, representing the most common and straightforward data partitioning scenario.
Gradient Leakage
A security vulnerability where raw model gradients shared during distributed training can be analytically inverted by a malicious server to reconstruct the private input data that generated them.
Data Poisoning Attack
An adversarial attack where a malicious participant injects corrupted or mislabeled data into the federated training process to degrade the global model's performance or introduce a backdoor trigger.
Byzantine Fault Tolerance (BFT)
The resilience property of a distributed system that allows it to reach correct consensus and continue operating reliably even when an arbitrary subset of participating nodes exhibits malicious or arbitrary behavior.
Federated Proximal Optimization (FedProx)
A federated optimization algorithm that adds a proximal term to the local objective function to constrain local updates, improving stability and convergence guarantees in highly heterogeneous data environments.
Personalized Federated Learning (pFL)
A federated learning strategy that moves beyond a single global model to create tailored local models for individual clients, balancing global knowledge sharing with local data specificity.
Trusted Execution Environment (TEE)
A hardware-enforced isolated area within a main processor that guarantees the confidentiality and integrity of code and data loaded inside it, protecting sensitive computation from the host operating system.
Split Learning
A privacy-preserving distributed deep learning technique where a neural network is partitioned between a client and server, with the client only sharing intermediate activations (smashed data) rather than raw inputs.
Federated Foundation Model
A large-scale pre-trained model adapted to a specific domain through federated fine-tuning, allowing multiple institutions to collaboratively customize a general model without centralizing sensitive data.
Federated Synthetic Data Generation
The process of training a generative model, such as a GAN or VAE, across decentralized data silos to produce a privacy-preserving synthetic dataset that mirrors the statistical properties of the combined real data.
Federated Hyperparameter Tuning
The process of systematically searching for the optimal model configuration across a decentralized network, balancing the exploration of hyperparameter combinations with the communication and privacy constraints of federation.
Federated Cohort Discovery
A privacy-preserving query process that allows researchers to identify and count patient populations matching specific clinical criteria across multiple institutional databases without moving or exposing individual-level data.
Federated Record Linkage
The privacy-preserving process of identifying and linking records that correspond to the same individual across disparate, decentralized databases without revealing the individual's identity to the linking party.
Federated SHAP
A distributed implementation of the SHapley Additive exPlanations algorithm that calculates feature importance scores for a global model by aggregating local explanations computed at each client site.
Federated Model Drift Detection
The continuous monitoring process that identifies statistical degradation in a federated model's predictive performance over time due to evolving data distributions across the decentralized client network.
Federated Causal Discovery
The application of causal inference algorithms across decentralized datasets to identify cause-and-effect relationships between variables without pooling potentially sensitive raw data into a single location.
Federated Survival Analysis
A privacy-preserving approach to building time-to-event prediction models, such as Cox proportional hazards models, by training collaboratively across multiple institutions without sharing patient-level time and censoring data.
Federated GWAS
A decentralized implementation of a Genome-Wide Association Study that allows biobanks to jointly compute statistical associations between genetic variants and traits without sharing individual-level genotype or phenotype data.
Federated Batch Effect Correction
A distributed computational method for harmonizing non-biological systematic technical variation across data from different sites or experiments without requiring the raw data to be centralized for joint normalization.
Federated Graph Learning
A framework for training graph neural networks on decentralized graph-structured data, where each client holds a subgraph of a larger global graph, enabling collaborative learning on distributed knowledge graphs or molecular networks.
Model Explainability in Diagnostics
Terms related to SHAP values and attention visualization for regulatory approval of AI diagnostics. Target: FDA submission teams and clinical decision support developers.
SHAP Values
A game-theoretic approach to explain the output of any machine learning model by computing the contribution of each feature to a prediction.
Attention Weights
Learned scalar values in a transformer model that determine the importance of different input tokens when computing a contextualized representation.
Gradient-weighted Class Activation Mapping (Grad-CAM)
A technique for producing visual explanations from convolutional neural networks by using the gradients of a target concept flowing into the final convolutional layer.
Local Interpretable Model-agnostic Explanations (LIME)
An algorithm that explains the prediction of any classifier by approximating it locally with an interpretable model.
Integrated Gradients
An axiomatic attribution method that assigns importance scores to input features by integrating the gradients of the model's output along a straight-line path from a baseline input.
Layer-wise Relevance Propagation (LRP)
A technique for explaining neural network decisions by decomposing the output prediction and redistributing relevance scores backward through the network's layers.
Saliency Maps
A visualization technique that highlights the pixels or regions of an input image that most influence a neural network's classification score.
Partial Dependence Plot (PDP)
A global explanation method that shows the marginal effect of one or two features on the predicted outcome of a machine learning model.
Counterfactual Explanations
A method that describes how to minimally change the input features of an instance to alter its prediction to a predefined target outcome.
Model Cards
Structured transparency documents that report the intended use, evaluation results, and ethical considerations of a trained machine learning model.
Good Machine Learning Practice (GMLP)
A set of best practices and standards for developing, validating, and monitoring AI/ML-enabled medical devices to ensure their safety and effectiveness.
Intrinsic Interpretability
A property of machine learning models, such as linear regression or decision trees, that are considered understandable by humans due to their simple structure.
Post-hoc Explainability
The application of interpretation methods to a trained, often opaque model to extract explanations for its predictions after the training process is complete.
Concept Activation Vectors (CAV)
A technique that provides explanations of neural network internal states in terms of human-friendly, high-level concepts rather than individual input features.
Faithfulness Metrics
Quantitative measures that assess how accurately an explanation method reflects the true reasoning process of the underlying machine learning model.
Causal Attribution
A method for explaining model predictions by identifying the input features that are direct causes of an outcome, often using a structural causal model.
Uncertainty Quantification
The process of estimating and characterizing the different sources of noise and model ignorance that contribute to the total predictive uncertainty of a model's output.
Conformal Prediction
A model-agnostic framework that produces prediction sets with a rigorous, finite-sample guarantee of marginal coverage without assuming a specific data distribution.
Out-of-distribution Detection (OOD Detection)
The task of identifying test inputs that are statistically different from the training data, on which a machine learning model's predictions are likely to be unreliable.
Biomarker Saliency
The application of feature attribution methods to identify which biological measurements most strongly influence a diagnostic model's prediction for a specific patient.
Adversarial Robustness
The ability of a machine learning model to maintain accurate predictions when presented with intentionally perturbed inputs designed to cause misclassification.
Expected Gradients
An extension of Integrated Gradients that averages attributions over multiple baselines sampled from a background dataset to reduce visual noise and improve explanation quality.
Network Dissection
A framework for quantifying the interpretability of individual hidden units in a convolutional neural network by measuring their alignment with human-labeled visual concepts.
Centered Kernel Alignment (CKA)
A similarity index used to compare representations learned by different neural networks, identifying correspondences between their hidden layers.
Expected Calibration Error (ECE)
A scalar summary statistic that measures the discrepancy between a model's predicted confidence scores and its empirical accuracy.
Decision Curve Analysis
A method for evaluating the clinical net benefit of a diagnostic test or predictive model by incorporating the relative harms of false-positive and false-negative results.
Differential Privacy
A mathematical framework that provides a provable guarantee of privacy by adding calibrated noise to computations, limiting the risk of inferring any single individual's data.
Federated Averaging (FedAvg)
A foundational algorithm for federated learning that trains a shared global model by averaging the locally-computed model updates from decentralized client devices.
Membership Inference Attack
A privacy attack where an adversary determines whether a specific data record was used to train a target machine learning model.
FDA Predetermined Change Control Plan (PCCP)
A regulatory mechanism allowing manufacturers of AI/ML-enabled medical devices to pre-specify planned modifications without requiring a new marketing submission.
Polygenic Risk Score Modeling
Terms related to aggregating the effects of many genetic variants to predict disease susceptibility. Target: Population health researchers and direct-to-consumer genetics engineers.
Polygenic Risk Score (PRS)
A quantitative metric that aggregates the estimated effects of numerous genetic variants across the genome to predict an individual's genetic susceptibility to a specific trait or disease.
Genome-Wide Association Study (GWAS)
A hypothesis-free statistical analysis scanning millions of genetic variants across the genome to identify genotype-phenotype associations in large population cohorts.
Linkage Disequilibrium (LD) Score Regression
A technique that uses the correlation structure between genetic variants to estimate heritability and genetic correlations from GWAS summary statistics while correcting for confounding.
Clumping and Thresholding (C+T)
A standard PRS construction method that selects independent genetic variants by pruning based on linkage disequilibrium and retaining only those below a specified p-value significance threshold.
Effect Allele
The specific genetic variant allele to which the estimated effect size from a GWAS is assigned, serving as the reference for calculating an individual's risk allele dosage.
SNP Heritability
The proportion of phenotypic variance in a population that is attributable to the additive effects of all measured single nucleotide polymorphisms.
Liability Threshold Model
A statistical framework assuming a continuous, unobserved liability distribution underlying a binary disease trait, where individuals exceeding a threshold are classified as affected cases.
Area Under the ROC Curve (AUC-ROC)
A threshold-independent metric evaluating a PRS model's discriminative ability to correctly rank a randomly selected case higher than a randomly selected control.
Variance Explained (R²)
The proportion of phenotypic variance in a target dataset accounted for by the polygenic risk score, quantifying the model's overall predictive power.
Odds Ratio (OR)
A measure of association quantifying the increased odds of disease for individuals in a higher PRS percentile compared to a reference group, often the remainder of the population.
Population Stratification
Systematic differences in allele frequencies and disease prevalence between subpopulations due to ancestry, which can confound GWAS and PRS analyses if not properly corrected.
Principal Component Analysis (PCA)
A dimensionality reduction technique applied to genetic data to infer and correct for population structure by modeling continuous axes of genetic ancestry variation.
LASSO Regression
A penalized regression method that performs simultaneous variant selection and effect estimation by applying an L1 penalty, shrinking many coefficients to exactly zero to create a sparse PRS model.
LDpred2
A Bayesian PRS method that uses a point-normal mixture prior on variant effect sizes and a Gibbs sampler to infer the posterior mean effect, modeling the genetic architecture without explicit p-value thresholding.
PRS-CS
A Bayesian polygenic prediction method that applies continuous shrinkage priors on SNP effect sizes, using GWAS summary statistics and an external LD reference panel to infer posterior effect sizes.
PLINK
A widely-used, open-source whole-genome association analysis toolset designed for performing quality control, LD pruning, and the computation of polygenic risk scores on large-scale genetic datasets.
Summary Statistics
Aggregated GWAS results including the effect allele, beta coefficient, standard error, and p-value for each variant, which serve as the base data for constructing polygenic risk scores without individual-level access.
Meta-Analysis
A statistical technique that combines summary statistics from multiple independent GWAS to increase statistical power for variant discovery and improve the generalizability of derived polygenic scores.
Winner's Curse Correction
A statistical adjustment applied to GWAS effect sizes to account for the overestimation bias that occurs when selecting variants based on their statistical significance in the discovery dataset.
Empirical Bayes
A statistical framework that estimates the prior distribution of genetic effects directly from the observed GWAS data, enabling adaptive shrinkage of effect size estimates for more robust PRS construction.
Cross-Ancestry PRS
A polygenic risk score developed and validated across diverse global populations to address the poor transferability of scores trained primarily in European-ancestry cohorts.
Genetic Correlation
A measure of the shared genetic architecture between two complex traits, quantifying the extent to which the same causal variants influence both phenotypes.
Fine-Mapping
A statistical process that prioritizes the most likely causal genetic variants within a GWAS-associated locus by modeling the complex patterns of linkage disequilibrium.
Genetic Architecture
The comprehensive characterization of the number, frequency, and effect size distribution of causal genetic variants underlying a complex trait, which informs the choice of the optimal PRS method.
Mendelian Randomization (MR)
A causal inference method that uses genetic variants as instrumental variables to test whether a modifiable risk factor has a causal effect on a disease outcome, distinct from prediction.
Instrumental Variable (IV)
A genetic variant used in Mendelian randomization that must be robustly associated with the exposure, not associated with confounders, and affect the outcome only through the exposure.
Absolute Risk
The probability that an individual will develop a specific disease within a defined time window, calculated by combining a polygenic risk score with population-level incidence rates and other risk factors.
Net Reclassification Improvement (NRI)
A metric quantifying the extent to which adding a PRS to a baseline clinical model correctly reassigns individuals to more appropriate risk categories, assessing clinical utility beyond discrimination.
Genomic Inflation Factor (λ)
A metric comparing the median observed test statistic distribution to the expected null distribution in a GWAS, used to detect systemic bias from population stratification or cryptic relatedness.
Imputation Accuracy
A measure of the confidence in statistically inferred genotypes at untyped variants, typically quantified by the squared correlation between imputed and true genotypes, which impacts downstream PRS reliability.
Drug-Target Interaction Prediction
Terms related to graph neural networks and docking simulations for identifying novel therapeutic targets. Target: Computational chemists and pharmaceutical R&D informatics leaders.
Graph Neural Network (GNN)
A deep learning architecture designed to operate directly on graph-structured data, learning node, edge, and global representations by recursively aggregating information from neighboring connections.
Molecular Docking
A computational method that predicts the preferred orientation and conformation of a small molecule ligand when bound to a target protein receptor to form a stable complex.
Binding Affinity Prediction
The quantitative estimation of the strength of the non-covalent interaction between a drug candidate and its biological target, typically expressed as a dissociation constant or free energy value.
Virtual Screening
A computational technique used to rapidly evaluate large chemical libraries to identify those molecular structures most likely to bind to a specific drug target.
Quantitative Structure-Activity Relationship (QSAR)
A computational modeling method that establishes a mathematical correlation between the structural and physicochemical properties of chemical compounds and their measured biological activities.
Pharmacophore Modeling
The abstraction of the essential steric and electronic features of a molecule necessary to ensure optimal supramolecular interactions with a specific biological target and trigger a therapeutic response.
Molecular Dynamics Simulation
A physics-based computational method for simulating the physical movements of atoms and molecules over time by numerically solving Newton's equations of motion for a system of interacting particles.
Free Energy Perturbation (FEP)
A rigorous statistical mechanics method for calculating the relative binding free energy between two ligands by computationally mutating one into the other through a non-physical alchemical pathway.
Scoring Function
A mathematical function used in molecular docking to approximate the binding free energy of a protein-ligand complex, enabling the rapid ranking of different binding poses and compounds.
Protein Data Bank (PDB)
The single worldwide archive of experimentally determined three-dimensional structural data of large biological molecules, including proteins and nucleic acids, used as the foundational dataset for structural bioinformatics.
Drug-Target Interaction Network
A bipartite or heterogeneous graph representation where nodes are drugs and targets, and edges represent known or predicted interactions, enabling systems-level polypharmacology analysis.
Geometric Deep Learning
An umbrella term for neural network architectures specifically designed to respect the symmetries and invariances of non-Euclidean data, such as the 3D rotational and translational symmetry of molecular structures.
Equivariant Neural Network
A neural network architecture that guarantees its output transforms predictably under input transformations like rotation, ensuring that the predicted properties of a molecule are independent of its orientation in 3D space.
Message Passing Neural Network (MPNN)
A general framework for graph neural networks where nodes iteratively update their hidden states by receiving and aggregating vector messages from their immediate neighbors.
Graph Attention Network (GAT)
A graph neural network variant that introduces a self-attention mechanism to compute a dynamic weighting for each neighboring node's contribution during the message-passing step.
Molecular Fingerprint
A bit-string or vector representation encoding the presence or absence of specific substructural features within a molecule, used as a fixed-length input for traditional machine learning models.
SMILES String
The Simplified Molecular-Input Line-Entry System, a specification for unambiguously describing the structure of chemical molecules using short ASCII strings.
Protein-Ligand Complex
The three-dimensional structural assembly formed by the non-covalent binding of a small molecule ligand within the binding pocket of a target protein.
Structure-Based Drug Design
A drug discovery paradigm that relies on knowledge of the three-dimensional structure of the biological target to design and optimize small molecules that bind to it with high affinity and specificity.
Root-Mean-Square Deviation (RMSD)
A standard quantitative measure of the average distance between the atoms of superimposed protein structures or docked ligand poses, used to assess prediction accuracy.
DeepChem
An open-source Python library built on TensorFlow and PyTorch that provides high-level tools for applying deep learning to drug discovery, materials science, and quantum chemistry.
AutoDock Vina
A widely used open-source molecular docking engine that employs a sophisticated empirical scoring function and an iterated local search global optimization algorithm for rapid pose prediction.
Conformational Sampling
The computational process of generating a diverse ensemble of low-energy three-dimensional shapes that a flexible ligand molecule can adopt in solution prior to binding.
Allosteric Site
A binding site on a protein target that is topographically distinct from the active orthosteric site, where ligand binding modulates protein function through a conformational change.
Tanimoto Similarity
A metric for comparing the similarity of two sets, most commonly applied to binary molecular fingerprints to quantify the structural overlap between two chemical compounds.
AUC-ROC
The Area Under the Receiver Operating Characteristic Curve, a threshold-independent performance metric evaluating a binary classifier's ability to distinguish between active and inactive compounds.
Enrichment Factor
A metric measuring how many more active compounds are found in a selected top fraction of a ranked virtual screening list compared to a random selection.
Scaffold Hopping
The identification of novel chemotypes with similar biological activity but a fundamentally different core molecular scaffold, used to escape intellectual property constraints or improve ADMET profiles.
Proteochemometric Modeling (PCM)
A machine learning approach that simultaneously models the interaction space by using descriptors from both the ligand and the protein target side, enabling predictions for previously unseen targets or ligands.
Protein Language Model
A large-scale deep learning model, often based on the Transformer architecture, pre-trained on massive protein sequence databases to learn the underlying grammar of protein structure and function.
Transformer Models for Genomics
Terms related to applying self-attention architectures to DNA and protein sequence data. Target: Deep learning researchers in biotech and genomic language model developers.
Genomic Language Model (gLM)
A class of transformer-based models trained on vast quantities of unlabeled DNA sequence data to learn contextual representations of nucleotides, enabling state-of-the-art performance on downstream prediction tasks like variant effect scoring and promoter identification.
DNA Tokenization
The process of segmenting raw nucleotide sequences into discrete, meaningful units (tokens) such as individual bases, overlapping k-mers, or byte-pair encoded subwords, which serve as the fundamental input vocabulary for genomic language models.
K-mer Tokenization
A DNA tokenization strategy that splits a genome sequence into overlapping or non-overlapping subsequences of fixed length k, balancing the trade-off between vocabulary size and the contextual information captured in each token.
Self-Attention
The core mechanism in transformer architectures that computes a weighted representation of every position in a sequence by dynamically assessing the relevance of all other positions, allowing the model to capture long-range dependencies between distal genomic elements.
Multi-Head Attention
An extension of the self-attention mechanism that runs multiple attention operations in parallel, enabling the model to simultaneously learn different types of relationships within a biological sequence, such as codon usage bias and transcription factor binding motifs.
Rotary Position Embedding (RoPE)
A method for encoding positional information in transformer models by rotating the query and key vectors, which naturally captures the relative distance between tokens and improves sequence length extrapolation in genomic contexts.
Sparse Attention
An efficient approximation of full self-attention where each token attends only to a predefined subset of other tokens, such as a local window or a dilated pattern, reducing the quadratic memory cost to enable the processing of extremely long genomic sequences.
State Space Model (SSM)
A sequence modeling architecture, exemplified by the Mamba model, that uses a linear time-invariant system to process long-range dependencies with linear computational complexity, offering a performant alternative to attention for whole-genome analysis.
Masked Language Modeling (MLM)
A self-supervised pre-training objective where a random subset of input tokens is masked and the model learns to predict the original nucleotides from the surrounding genomic context, forcing it to learn fundamental regulatory grammar and sequence conservation patterns.
Variant Effect Prediction
The computational task of using a genomic language model to score the functional impact of single-nucleotide polymorphisms or mutations, distinguishing benign genetic variation from pathogenic variants without task-specific training data.
Zero-Shot Mutation Prediction
The application of a pre-trained protein or genomic language model to predict the effect of a mutation using only the difference in sequence likelihood, without any supervised fine-tuning on labeled variant effect data.
Enhancer-Gene Linking
A predictive genomics task that uses transformer models to map distal regulatory elements, such as enhancers, to their target gene promoters by learning the complex, long-range chromatin interaction patterns from DNA sequence alone.
DNABERT
A pioneering genomic language model that adapts the BERT architecture by training on human genome sequences with k-mer tokenization to capture regulatory element syntax for tasks like promoter and splice site prediction.
Enformer
A transformer-based deep learning architecture developed by DeepMind that predicts gene expression and epigenetic tracks directly from DNA sequence, dramatically increasing the receptive field to capture distal enhancer-gene interactions up to 100 kilobases away.
Nucleotide Transformer
A set of state-of-the-art genomic foundation models pre-trained on diverse DNA sequences from multiple species, designed to provide robust, transferable nucleotide embeddings for a wide range of downstream genomic prediction tasks.
Protein Language Model (pLM)
A transformer model trained on massive databases of protein amino acid sequences using self-supervised objectives, which learns the underlying grammar of protein structure and function to generate informative embeddings for structure prediction and variant effect scoring.
Evolutionary Scale Modeling (ESM-2)
A family of large-scale protein language models from Meta AI that uses masked language modeling on millions of evolutionary diverse sequences to capture deep structural, functional, and evolutionary information within learned protein representations.
Contact Prediction
The task of determining which pairs of amino acid residues are in close spatial proximity within a folded protein's three-dimensional structure, a capability that emerges in the attention heads of protein language models and is foundational to de novo structure prediction.
In-Silico Mutagenesis
A computational technique that systematically introduces virtual mutations into a DNA or protein sequence and uses a pre-trained model to measure the resulting change in predicted function or stability, generating a comprehensive effect map for every possible single-nucleotide change.
Attention Heatmap
A visualization of the self-attention weights from a transformer model, used as an interpretability tool to identify which specific nucleotides or amino acids the model focuses on when making a prediction, thereby revealing potential binding sites or structural contacts.
Parameter-Efficient Fine-Tuning (PEFT)
A set of adaptation techniques, including Low-Rank Adaptation (LoRA) and adapter modules, that update only a tiny fraction of a pre-trained genomic model's parameters, enabling cost-effective specialization for a specific downstream task like cell-type-specific expression prediction.
Cross-Species Transfer Learning
The practice of fine-tuning a genomic language model pre-trained on one species, such as human, to perform regulatory prediction tasks in a different species with limited labeled data, leveraging the conservation of fundamental biological sequence grammar.
Genomic Benchmarks
A standardized suite of curated datasets and evaluation protocols designed to rigorously compare the performance of different genomic language models on a diverse set of nucleotide-level classification tasks, such as enhancer identification and chromatin accessibility prediction.
Motif Discovery
The process of using the attention weights or learned embeddings of a transformer model to identify recurring, biologically meaningful sequence patterns, such as transcription factor binding motifs, directly from raw DNA without prior knowledge.
3D Genome Folding
The computational prediction of the three-dimensional spatial organization of chromatin inside the nucleus from DNA sequence, a task where transformer models learn to predict Hi-C contact maps and identify topologically associating domains.
Single-Cell Embedding
A representation learning technique where a transformer model processes single-cell gene expression data to project each cell into a low-dimensional vector space, capturing its functional state and enabling clustering, trajectory inference, and batch correction.
De Novo Protein Design
The generative task of creating entirely novel protein sequences predicted to fold into a desired three-dimensional structure, often achieved using inverse folding models, diffusion models, or protein language models fine-tuned on structural data.
Geometric Deep Learning
A paradigm for designing neural networks that respect the inherent symmetries of three-dimensional biomolecular structures, using architectures like SE(3) Transformers and equivariant graph neural networks to process atomic coordinates for structure prediction and design.
Sequence Conservation
A measure of the degree to which a nucleotide or amino acid position remains unchanged across evolutionary time, a fundamental signal learned by transformer models during self-supervised pre-training that correlates strongly with functional importance.
Homology Detection
The computational task of identifying evolutionarily related sequences, where protein language model embeddings have proven superior to traditional alignment-based methods for detecting remote homologs that share structural and functional similarity but have highly diverged sequences.
Partnered with leading AI, data, and software stack.
How We Work
Custom AI workflows for your Business
One-fit-all AI don't work for modern businesses. At Inferensys, we aim to understand your business & custom requirements; which we use to define most efficient agentic workflows, the data, and the tools for your business.
01
Review the use case
We understand the task, the users, and where AI can actually help.
Read more02
Pick the right approach
We define what needs search, automation, or product integration.
Read more03
Build the first useful version
We implement the part that proves the value first.
Read more04
Improve from there
We add the checks and visibility needed to keep it useful.
Read moreThe first call is a practical review of your use case and the right next step.
Talk to Us